Core Viewpoint - The internal control evaluation report of Ben Steel Plate Co., Ltd. emphasizes the importance of enhancing internal control systems to mitigate operational risks and improve governance capabilities in line with national directives [1][2]. Internal Control Evaluation Conclusion - The company has not identified any significant defects in financial reporting internal controls as of the evaluation report date, indicating effective internal controls in all major aspects [2][3]. - No significant defects in non-financial reporting internal controls were found during the evaluation period [2][3]. Internal Control Evaluation Work - An internal control evaluation working group was established to implement the annual evaluation, focusing on high-risk areas and core business sectors [3][4]. Scope of Internal Control Evaluation - The evaluation covered various units and business activities, including governance, strategic planning, and financial management, ensuring comprehensive coverage of the company's operations [3][4]. Standards for Identifying Internal Control Defects - The company has established specific standards for identifying internal control defects, categorized into financial and non-financial reporting defects, maintaining consistency with previous years [4][5]. Internal Control Defect Identification and Rectification - Throughout the reporting period, the company did not encounter any significant or important defects in either financial or non-financial reporting internal controls [6][7]. Other Significant Internal Control Matters - The company plans to enhance its internal control systems further and implement regular inspections to ensure ongoing compliance and optimization of the internal control framework [7].

长虹美菱股份有限公司 综上所述，监事会认为：公司 2024 年度内部控制评价报告全面、客观、真 实地反映了公司内部控制体系的建设及运行情况，有效地控制了经营风险。监事 会对公司 2024 年度内部控制评价报告无异议。 （此页无正文，专用于《长虹美菱股份有限公司监事会关于公司 2024 年度内部 控制评价报告的意见》签字页） 签名： 邱 锦 监事会关于公司 2024 年度内部控制评价报告的意见 根据《企业内部控制基本规范》及其配套指引的规定和证监会、财政部联合 下发的《公开发行证券的公司信息披露编报规则第 21 号——年度内部控制评价 报告的一般规定》、《深圳证券交易所股票上市规则》等有关规定，通过认真审 核董事会出具的《公司 2024 年度内部控制评价报告》内容，并与公司管理层和 有关管理部门交流，查阅公司的管理制度,公司监事会发表意见如下： 一、公司根据中国证监会、安徽证监局、深圳证券交易所的有关规定，遵循 内部控制的基本原则，结合自身的实际情况，建立健全了覆盖公司各环节的内部 控制制度，保证了公司业务活动的正常进行，保护公司资产的安全和完整，有效 防范和降低经营过程中的风险。公司如实编制 2024 年度内 ...

渤海租赁股份有限公司全体股东： 按照《企业内部控制审计指引》及中国注册会计师执业准则的相关要求，我们审计了渤海 租赁股份有限公司（以下简称"渤海租赁"）2024 年 12 月 31 日的财务报告内部控制的有效性。 一、企业对内部控制的责任 按照《企业内部控制基本规范》、《企业内部控制应用指引》、《企业内部控制评价指引》的 规定，建立健全和有效实施内部控制，并评价其有效性是渤海租赁董事会的责任。 二、注册会计师的责任 我们的责任是在实施审计工作的基础上，对财务报告内部控制的有效性发表审计意见，并 对注意到的非财务报告内部控制的重大缺陷进行披露。 渤海租赁股份有限公司 A member firm of Ernst & Young Global Limited 安永华明（2025）专字第70018799_A01号 渤海租赁股份有限公司 渤海租赁股份有限公司 安永华明（2025）专字第70018799_A01号 渤海租赁股份有限公司 （本页无正文） 安永华明会计师事务所（特殊普通合伙） 中国注册会计师：王 敏 中国注册会计师：张 莹 三、内部控制的固有局限性 内部控制具有固有局限性，存在不能防止和发现错误的可能性。此 ...

Meeting Overview - The 14th meeting of the 10th Supervisory Board of Bohai Leasing was held on April 1, 2025, in Beijing, with all three supervisors present [1] - The meeting was conducted in accordance with relevant laws and regulations, and all resolutions were passed unanimously [1] Resolutions Passed - The Supervisory Board approved the 2024 Annual Work Report, which will be submitted to the 2024 Annual General Meeting for review [2][3] - The 2024 Annual Report and its summary were deemed to accurately reflect the company's situation and will also be submitted for shareholder approval [2][3] - The profit distribution plan for 2024 was proposed, which includes no cash dividends, no bonus shares, and no capital increase from reserves [2][3] Internal Control and Governance - The Supervisory Board confirmed that the 2024 Internal Control Evaluation Report accurately reflects the company's governance and internal control status, with no significant deficiencies identified [3] - A three-year shareholder return plan (2025-2027) was approved, considering the company's operational conditions and external financing environment [5] Board and Supervisory Changes - The Supervisory Board will undergo a re-election process due to the expiration of the current term, with candidates proposed for the 11th Supervisory Board [5][6] - The proposed non-employee supervisors are Zhou Peixuan and Ma Li, whose qualifications meet regulatory requirements [8][9] Compensation Standards - The proposed compensation for non-independent directors is set at a net annual amount of 36,000 RMB, applicable during the term of the 11th Board [6]

Core Viewpoint - The internal control evaluation report of Shenzhen Shenghong Electric Co., Ltd. aims to enhance internal control, improve management levels, and ensure sustainable development while protecting investors' rights [1][2]. Internal Control Objectives - The internal control system is designed to ensure legal compliance in operations, asset security, and the authenticity of financial reporting, thereby promoting operational efficiency and strategic development [2]. Evaluation Basis - The internal control evaluation is conducted based on the "Basic Norms for Enterprise Internal Control" and related guidelines, utilizing interviews, surveys, sampling, and comparative analysis to gather evidence on the effectiveness of internal controls [2][3]. Internal Control Coverage - The internal control system encompasses all operational aspects of Shenzhen Shenghong Electric Co., Ltd. and its subsidiaries, focusing on high-risk areas such as sales, procurement, and related transactions [3]. Evaluation Principles - The evaluation adheres to principles of comprehensiveness, significance, and independence to ensure an objective and complete assessment [3]. Internal Control Defect Standards - The company has established specific standards for identifying internal control defects, differentiating between major, significant, and general defects based on both qualitative and quantitative criteria [4][5]. Key Internal Control Activities - The company has implemented strict internal controls for related transactions, fundraising usage, and information disclosure, ensuring compliance with legal requirements and protecting shareholder interests [8]. Governance Structure - The governance structure includes a shareholders' meeting, board of directors, and supervisory board, with established rules and regulations to ensure independent operation and mutual checks among various bodies [9]. Organizational Structure - The company has a clear organizational structure with defined roles and responsibilities across departments, ensuring effective operational management and control [9][10]. Internal Audit Supervision - An audit committee under the board of directors oversees internal and external audits, ensuring effective communication and supervision of internal controls [10]. Development Strategy - The strategic committee of the board is responsible for long-term development strategies and major investment decisions, contributing positively to the company's strategic planning [11]. Corporate Culture - The company emphasizes building a positive corporate culture and social responsibility, fostering values such as integrity, dedication, and teamwork [11]. Social Responsibility - The company is committed to enhancing energy efficiency and contributing to social development through various charitable initiatives [11]. Human Resources - The company has established human resource policies that promote sustainable development, including performance evaluation and training programs for employees [12]. Sales and Procurement Management - The company has developed comprehensive management systems for sales and procurement, ensuring effective market expansion and compliance with operational procedures [12][13]. Inventory Management - The company has implemented a robust asset management system to control inventory processes and prevent losses [14]. External Guarantee Management - The company has a clear management system for external guarantees, ensuring compliance with regulations and minimizing operational risks [14]. Financial Reporting - The company maintains a rigorous financial management system, ensuring the accuracy and completeness of financial reporting [14][15]. Product Development - The company has established a structured product development process to enhance market-oriented capabilities and improve product competitiveness [15][16]. Internal Control Defect Recognition - During the reporting period, no major or significant internal control defects were identified in both financial and non-financial reporting [16].

《公司 2023 年年度报告》等议案，通报了内部审计工作检查 况报告》 《重 庆水务集团股份有限公司章程》及《重庆水务集团股份有限公司董事 会专门委员会工作规则》的相关规定，重庆水务集团股份有限公司（下 称公司）董事会审计委员会（下称审计委员会）在 2024 年度内勤勉 尽责，充分发挥了审计委员会的职责和作用，现将 2024 年度履职情 况汇报如下： 一、审计委员会委员基本情况 重庆水务集团股份有限公司董事会 审计委员会 2024 年度履职情况报告 按照《上市公司治理准则》 《上海证券交易所股票上市规则》 公司第五届董事会审计委员会经公司第五届董事会第一次会议 选举产生，由石慧女士、代伟先生、傅达清先生三名董事组成，其中 石慧女士、傅达清先生为独立董事，代伟先生为公司董事，石慧女士 为会计专业人士及审计委员会召集人。公司第五届董事会审计委员会 原定任期至 2024 年 3 月 8 日止。 审计委员会经公司第六届董事会第一次会议选举产生，由石慧女士、 代伟先生、傅达清先生三名董事组成，其中石慧女士、傅达清先生为 独立董事，代伟先生为公司董事。石慧女士为会计专业人士及审计委 员会召集人。 二、审计委员会会议召开情 ...

一. 重要声明 按照企业内部控制规范体系的规定，建立健全和有效实施内部控制，评价其有效性，并如实披露内 部控制评价报告是公司董事会的责任。监事会对董事会建立和实施内部控制进行监督。经理层负责组织 领导企业内部控制的日常运行。公司董事会、监事会及董事、监事、高级管理人员保证本报告内容不存 在任何虚假记载、误导性陈述或重大遗漏，并对报告内容的真实性、准确性和完整性承担个别及连带法 律责任。 公司内部控制的目标是合理保证经营管理合法合规、资产安全、财务报告及相关信息真实完整，提 高经营效率和效果，促进实现发展战略。由于内部控制存在的固有局限性，故仅能为实现上述目标提供 合理保证。此外，由于情况的变化可能导致内部控制变得不恰当，或对控制政策和程序遵循的程度降 低， 根据内部控制评价结果推测未来内部控制的有效性具有一定的风险。 二. 内部控制评价结论 □是 √否 公司代码：601698 公司简称：中国卫通 中国卫通集团股份有限公司 中国卫通集团股份有限公司全体股东： 根据《企业内部控制基本规范》及其配套指引的规定和其他内部控制监管要求（以下简称企业内部 控制规范体系），结合本公司（以下简称公司）内部控制制度和评价办法， ...

公司代码：600938 公司简称：中国海油 中国海洋石油有限公司 中国海洋石油有限公司全体股东： 公司内部控制的目标是合理保证经营管理合法合规、资产安全、财务报告及相关信息真实完整， 提 根据《企业内部控制基本规范》及其配套指引的规定和Committee of Sponsoring Organization （以下简称"COSO委员会"）制定的内部控制框架（以下简称"企业内部控制规范体系"），结合中国海 洋石油有限公司（以下简称"公司"）内部控制制度和评价办法，在内部控制日常监督和专项监督的基 础上，我们对公司2024年12月31日（内部控制评价报告基准日）的内部控制有效性进行了评价。 一. 重要说明 高经营效率和效果，促进实现发展战略。由于内部控制存在的固有局限性，故仅能为实现上述目标提供 合理保证。此外，由于情况的变化可能导致内部控制变得不恰当，或对控制政策和程序遵循的程度降 低， 公司董事会的职责是确保本公司建立和维持适当且有效的风险管理和内控控制系统、审视其有效 性、并确保公司对内部控制评价报告进行如实披露。在公司董事会监督下，公司管理层负责建立健全和 有效实施内部控制，并对有效性做出自检查和评价。公 ...

Core Viewpoint - The internal control evaluation report of China Merchants Energy Transportation Co., Ltd. indicates that the company has maintained effective internal controls over financial reporting and has not identified any significant deficiencies as of December 31, 2024 [2][8]. Internal Control Evaluation Conclusion - The company has confirmed that there are no significant deficiencies in financial reporting internal controls [2][8]. - There are no significant deficiencies identified in non-financial reporting internal controls [2][8]. - No factors affecting the effectiveness of internal control evaluations have occurred between the evaluation date and the report issuance date [2][8]. Internal Control Evaluation Work - The evaluation scope included major units, businesses, and high-risk areas based on a risk-oriented principle [3][4]. - The total assets and total operating income of the evaluated units accounted for 100% of the company's consolidated financial statements [3][4]. - The company has identified and assessed internal control deficiencies across 118 primary processes, 289 secondary processes, and 690 tertiary processes, ensuring timely and effective rectification [3][4][10]. Internal Control Deficiency Recognition and Rectification - The company has identified a total of 27 internal control deficiencies through self-assessment in 2024 [8][10]. - A total of 34 internal control deficiencies have been rectified, including 21 from previous years and 13 newly identified in 2024 [8][10]. - The company will continue to monitor and follow up on unresolved internal control deficiencies to enhance the internal control system [8][10]. Future Internal Control Management - The company plans to enhance the internal control system's coverage and quality, focusing on the completeness and execution of the internal control framework [10][11]. - There will be an emphasis on risk identification and assessment to proactively manage potential risks [11][12]. - The company aims to improve the digitalization of internal control management, particularly in credit risk management, to ensure automated and intelligent execution of control measures [12].

公司代码：688331 公司简称：荣昌生物 荣昌生物制药（烟台）股份有限公司 荣昌生物制药（烟台）股份有限公司全体股东： 根据《企业内部控制基本规范》及其配套指引的规定和其他内部控制监管要求（以下简称企业内部 控制规范体系），结合本公司（以下简称公司）内部控制制度和评价办法，在内部控制日常监督和专项 监督的基础上，我们对公司2024年12月31日（内部控制评价报告基准日）的内部控制有效性进行了评 价。 一. 重要声明 按照企业内部控制规范体系的规定，建立健全和有效实施内部控制，评价其有效性，并如实披露内 部控制评价报告是公司董事会的责任。监事会对董事会建立和实施内部控制进行监督。经理层负责组织 领导企业内部控制的日常运行。公司董事会、监事会及董事、监事、高级管理人员保证本报告内容不存 在任何虚假记载、误导性陈述或重大遗漏，并对报告内容的真实性、准确性和完整性承担个别及连带法 律责任。 公司内部控制的目标是合理保证经营管理合法合规、资产安全、财务报告及相关信息真实完整，提 高经营效率和效果，促进实现发展战略。由于内部控制存在的固有局限性，故仅能为实现上述目标提供 合理保证。此外，由于情况的变化可能导致内部控制变 ...